Our results suggest a lack of sympatho-vagal balance activation in the first 5 min of tilt test in subjects with vasovagal syncope. CI and VD syncope groups show a lower decrease of HF indices in the Early5. Moreover, CI
group shows a lower increase of LF indices. A perspective of this work is the set of cut-off values from data recorded over the first 5 min of tilt test to estimate the risk and the type of vasovagal reaction, based on a bigger population.
Effects and mechanisms of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation
Ali Houeijeh (1), Ali Houeijeh (1), Helene Coridon (2), Karine Montaigne (2), Estelle Aubry (2), Rony Sfeir (2), Philippe Deruelle (2), François Godart (1), Laurent Storme (2 The effect of n-3 polyunsaturated fatty acids in the pulmonary circulatory is not well defined. This question is clinically relevant in respiratory failure associated with pulmonary hypertension. To investigate this effect we have realised a randomized, placebo-controlled comparative study on sixty-two chronically prepared lamb fetuses.
Methods: Catheters and ultrasonic flow transducer were placed through a left thoracotomy in the lamb fetus to determine aortic, pulmonary, and left atrial pressures and left pulmonary artery blood flow. We compared the pulmonary vascular responses to 120 min of Omegaven (lipid emulsions enriched in n-3 polyunsaturated fatty acids) or Intralipide (lipid emulsions enriched in n-6 polyunsaturated fatty acids) infusion. Then we investigated the effects of Omegaven on the pulmonary circulation after nitric oxide synthase inhibition by L-nitro-arginine, potassium channel blockade by tetraethylammonium, cytochrome P450 epoxygenase inhibition by (methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide, and cyclo-oxygenase inhibition by Ibuprofen.
Results:
Pulmonary artery and aortic pressures as well as blood gases and plasma lactate concentrations did not change during either fat emulsion infusion. Left pulmonary blood flow increased by 30% and pulmonary vascular resistance decreased by 28% during Omegaven infusion, whereas they did not change during Intralipide infusion. This pulmonary vascular response to Omegaven was not altered by l-nitro-arginine or Ibuprofen infusion. At the opposite, Omegaven induced pulmonary vasodilatation was abolished by tetraethylammonium and markedly attenuated by (methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide.
Conclusion:
Lipid emulsion containing n-3 polyunsaturated fatty acids may induce a potent and sustained vasodilatation in the fetal lung. This pulmonary vasodilator response is mediated through production of vasoactive mediators by cytochrome P450 epoxygenase and through activation of potassium channels.
Phosphatidylcholine distribution between lipoprotein fractions in patients with CAD
Ymène Nekaies (1), Ali Ben Khalfallah (2), Hanène Aoua (1), Kamel Charradi (3), Mohsen Sakly (1), Nebil Attia (4) (1) Faculté des sciences de Bizerte, UR de physiologie intégrée, Bizerte, Tunisie -(2) Hôpital Régional de Menzel Bourguiba, service de cardiologie, Menzel Bourguiba, Tunisie -(3) Centre de biotechnologie, Laboratoire des substances bioactives, Borj Cedria, Tunisie -(4) Faculté des sciences de Bizerte, Département de biologie, Jarzouna-Bizerte, Tunisie Background and objectives: Recent data have shown that phospholipids (mainly phosphatidylcholine) transfer activity is associated to metabolic syndrom and coronary artery disease (CAD). This transfer activity could modulate the phosphatidylcholine (PC) distribution between lipoprotein subclasses. In this study we separated lipoprotein fractions and we analyzed PC distribution.
Methods: Ninety two subjects were recruited (47 CAD patients and 45 age-and sex-matched controls). Antropometric measurements, lipid profile and PC analysis were performed.
Results:
Despite from an abnormal lipid profile: elevated serum triglycerides and LDL-C, and low HDL-C (but total cholesterol level was not significantly different between controls and CAD patients), serum PC centrations were slightly higher in CAD patients than in controls (respectively 2.53±0.84 and 2.36±0.43 mmol/L, ns). The level of PC was significanly higher in patients, compared to controls, concerning the (VLDL+LDL) fraction (p<0.01). In concomitance, HDL-PC was descreased in CAD patients in comparison with controls (p<0.05). Furthermore, serum PC level was colsely correlated to waist/hip ratio only in CAD patients (p=0.0013). However, PC concentrations were less closely associated to BMI in the same group (p<0.035).
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